GBA1 and Gaucher disease: Importantly, the levels of sGpnmb in circulation significantly correlated with chitotriosidase enzymatic activity (Fig 10F), a biomarker used to evaluate disease severity and progression in Gaucher disease patients with a deficiency in lysosomal glucocerebrosidase [36] and also used in NPC diagnosis [45].